10-Q: PureCycle Secures $300M, Fuels Global Recycling Expansion

PureCycle Technologies raised $300 million in Series B Preferred Stock, alleviating going concern doubts and accelerating global expansion plans for new polypropylene recycling facilities.

Summary

• Net loss for the three months ended June 30, 2025, was $(144.2) million, and $(135.4) million for the six months ended June 30, 2025.
• Generated revenues of $1.7 million for the three months and $3.2 million for the six months ended June 30, 2025, marking the first year of meaningful operations and sales.
• Cash and cash equivalents significantly increased to $284.1 million as of June 30, 2025, from $15.7 million at December 31, 2024.
• Successfully raised $300.0 million through the issuance of Series B Convertible Perpetual Preferred Stock in June 2025, which alleviated previous substantial doubt about the company's ability to continue as a going concern.
• Announced ambitious global expansion plans including a 130.0 million pound polypropylene recycling facility in Thailand (operational mid-2027), a 130.0 million pound facility in Antwerp, Belgium (operational 2028), and a 300.0 million pound multi-line purification facility in Augusta, Georgia (PreP operational mid-2026, first purification line 2029).
• Received an additional FDA Letter of No Objection (LNO) in July 2025, expanding the use of PureFive resin for all food types under broader process conditions.
• Operating loss for the three months ended June 30, 2025, was $(45.6) million, an increase from $(39.9) million in the prior year period.
• Total liabilities increased to $649.5 million as of June 30, 2025, from $617.9 million at December 31, 2024.
• The change in fair value of warrants resulted in an $82.3 million expense for the three months ended June 30, 2025, primarily due to an increase in the underlying common stock value.
• The Piot derivative action, a lawsuit against certain officers and directors, was dismissed with prejudice by the Chancery Court of Delaware on July 23, 2025.

Sentiment

Score: 7

Explanation: While operational losses persist as the company scales, the significant capital raise, alleviation of going concern doubts, and aggressive global expansion plans indicate strong positive momentum and investor confidence in the long-term vision, outweighing current financial performance.

Positives

• Successfully raised $300.0 million through the issuance of Series B Convertible Perpetual Preferred Stock, significantly improving liquidity and alleviating previous going concern doubts.
• Cash and cash equivalents increased substantially to $284.1 million as of June 30, 2025, from $15.7 million at December 31, 2024.
• Announced ambitious global expansion plans for new polypropylene recycling facilities in Thailand, Belgium, and Augusta, Georgia, targeting 560 million pounds of new capacity.
• Received an additional FDA Letter of No Objection (LNO) in July 2025, expanding the use of PureFive resin for all food types under broader process conditions, indicating product versatility and regulatory acceptance.
• Generated first meaningful revenues of $3.2 million for the six months ended June 30, 2025, indicating progress in commercialization.
• The Piot derivative action, a lawsuit against certain officers and directors, was dismissed with prejudice on July 23, 2025.
• The Sylebra Revolving Credit Facility maturity date was extended from March 31, 2026, to September 30, 2026.

Negatives

• Continued significant net losses of $(144.2) million for the three months and $(135.4) million for the six months ended June 30, 2025.
• Operating loss increased to $(45.6) million for the three months ended June 30, 2025, from $(39.9) million in the prior year period.
• Cost of operations increased by $7.8 million for the three months and $9.9 million for the six months ended June 30, 2025, partly due to a $3.7 million loss on disposal of fixed assets.
• Interest expense increased by $5.6 million for both the three and six months ended June 30, 2025, due to increased outstanding debt and interest paid on the Sylebra line of credit.
• Change in fair value of warrants resulted in an $82.3 million expense for the three months and $25.6 million for the six months ended June 30, 2025, primarily due to an increase in the underlying common stock value.
• Accumulated deficit grew to $(768.8) million as of June 30, 2025, from $(633.4) million at December 31, 2024.
• The Denham-Blythe arbitration, involving claims of approximately $17.0 million against a subsidiary, remains ongoing with an uncertain outcome.

Risks

• Ability to obtain funding for operations and future growth and to continue as a going concern.
• Ability to meet, and to continue to meet, applicable regulatory requirements for the use of PureFive resin in food grade applications (including in the United States, Europe, Asia and other future international locations).
• Ability to comply on an ongoing basis with the numerous regulatory requirements applicable to the PureFive resin and facilities.
• The Ironton Facility's ability to be appropriately certified and commence full-scale commercial operations in a timely and cost-effective manner, or at all.
• Ability to meet, and to continue to meet, the requirements imposed by funding for operations, including the Ironton Facility.
• Many hazards and operational risks at manufacturing facilities that can result in potential injury, business disruption, liability, and increased costs.
• Ability to complete the necessary funding with respect to, and complete the construction of new polypropylene recycling facilities in Thailand, Antwerp, Belgium, and Augusta, Georgia in a timely and cost-effective manner.
• Ability to execute growth plan to bring an additional one billion pounds of installed polypropylene recycling capability online before 2030, including meeting related construction, regulatory, and financing requirements.
• Ability to procure, sort and process polypropylene plastic waste at planned plastic waste prep (Feed PreP) facilities.
• Ability to maintain exclusivity under The Procter & Gamble Company (P&G) license.
• The success or profitability of offtake arrangements.
• Potential impact of economic, business, and/or competitive factors, including interest rates, availability of capital, economic cycles, and other macro-economic impacts (such as tariffs).
• Changes in the prices and availability of materials (such as steel and other materials needed for construction), including those changes caused by inflation, tariffs and supply chain conditions, and the ability to obtain such materials in a timely and cost-effective manner.
• Ability to source feedstock with a high polypropylene content at a reasonable cost.
• The outcome of any legal or regulatory proceedings to which the company is, or may become, a party including the securities class action and putative class action cases.
• Geopolitical risk and changes in applicable laws or regulations.
• The possibility that the company may be adversely affected by other economic, business, and/or competitive factors.
• Turnover in employees and increases in employee-related costs.
• Changes in the prices and availability of labor (including labor shortages).
• Any business disruptions due to political or economic instability, pandemics, armed hostilities (including the ongoing conflict between Russia and Ukraine and the conflict in the Middle East).
• The potential impact of climate change on the company, including physical and transition risks, higher regulatory and compliance costs, reputational risks, and availability of capital on attractive terms.
• Operational risk.

Future Outlook

The company plans to significantly increase its installed capacity by constructing new polypropylene recycling facilities: a 130.0 million pound facility in Thailand, expected to be operational by mid-2027; a 130.0 million pound facility in Antwerp, Belgium, projected to be operational in 2028; and a 300.0 million pound multi-line purification facility in Augusta, Georgia, with PreP facilities operational by mid-2026 and the first purification line by 2029. These initiatives aim to bring an additional one billion pounds of installed polypropylene recycling capability online before 2030. The company also intends to conduct additional testing and make further FDA LNO submissions for expanded post-consumer recycled feedstock sources and Conditions of Use.

Management Comments

• "The Company's current financial projections support the Company's ability to meet its obligations as they become due for at least the twelve-month period from the date that these financial statements were issued."
• "The Company's ability to continue as a going concern longer term is dependent on continued improvement in operations at our Ironton Facility, the commercialization of our PureFive TM resin product, and the successful construction and sale of product from our Thailand facility."
• "Management continues to evaluate different strategies and may pursue additional actions to further increase its liquidity position."

Industry Context

The company operates in the rapidly expanding circular economy and sustainability sector, addressing the global challenge of polypropylene waste. Its patented purification recycling technology, licensed from P&G, positions it as a key player in transforming waste into near-virgin resin. This technology supports multinational corporations in achieving their sustainability goals and complying with federal and state regulations. The announced global expansion plans align with the increasing industry demand for high-quality recycled content and sustainable product solutions, indicating a strategic move to capture a larger share of this growing market.

Comparison to Industry Standards

• The company's global license for patented purification recycling technology from P&G provides a unique competitive advantage, differentiating its PureFive resin from standard recycled polypropylene offerings.
• The planned capacity expansion of 560 million pounds across new facilities in Thailand, Belgium, and Augusta, Georgia, demonstrates a significant commitment to scaling operations and contributing substantially to the global supply of recycled polypropylene, a key benchmark for sustainability in the plastics industry.
• The receipt of an additional FDA Letter of No Objection (LNO) for food contact grade resins under broader process conditions positions the company favorably in high-value, regulated applications, which is a critical differentiator in the recycled plastics market.
• The strategy to leverage existing site infrastructure, such as IRPC's eco-industrial zone in Rayong, Thailand, for cost reduction in construction activities, reflects an industry-standard approach to optimizing capital expenditure for large-scale industrial projects.

Management Changes

Corporate Governance

Legal Proceedings

• **Denham-Blythe Arbitration**: An ongoing arbitration with Denham-Blythe Company, Inc. (DB) regarding disputes over unapproved change orders and payment applications. DB seeks approximately $17.0 million plus attorney's fees and arbitration costs. PCO, a subsidiary, filed a counterclaim alleging damages in excess of DB's claim due to deficiencies in DB's work. ISC Constructors, a DB subcontractor, also filed an action for $0.5 million in unpaid invoices, which has been consolidated with the AAA arbitration. The company cannot reasonably estimate at this time whether there will be any loss, or the possible range of loss.
• **Piot Derivative Action**: A derivative action initiated by Selim Piot against certain officers and directors was dismissed with prejudice by the Chancery Court of Delaware on July 23, 2025. The claims were substantially similar to previously resolved derivative lawsuits.

Related Party Transactions

• **Sylebra Capital Management (Sylebra)**: Lenders in the $200.0 million Revolving Credit Facility (undrawn as of June 30, 2025, but $10.0 million drawn and repaid in June 2025). Affiliates purchased $50.0 million aggregate principal amount of Green Convertible Notes. Investment entities affiliated with Sylebra participated in the Series B Convertible Perpetual Preferred Stock offering and Common Stock private placement.
• **Samlyn Capital, LLC (Samlyn)**: Investment entities affiliated with Samlyn participated in the Series B Convertible Perpetual Preferred Stock offering and Common Stock private placement.
• **Pure Plastics LLC (Pure Plastic)**: Executed a 30-day promissory note for $4.9 million in June 2025, repaid with $0.02 million interest. Issued Series B Warrants to Pure Plastic.
• **Pure Crown LLC (Pure Crown)**: Investment entities affiliated with Pure Crown participated in the Series B Convertible Perpetual Preferred Stock offering.
• **Glockner Family Venture Fund LP, Glockner Enterprises, and Glockner Oil (Glockner)**: Related parties. Glockner exercised 0.1 million Series A Warrants on July 28, 2025, for $1.2 million cash.
• **Milliken & Company (Milliken)**: Purchased $0.4 million and $0.5 million of certain chemicals from Milliken during the three and six months ended June 30, 2025, respectively.
• **Related Party Bonds Payable**: PCT LLC sold $11.4 million in aggregate principal amount of its Senior Bonds to related parties for gross proceeds of $10.1 million during the six months ended June 30, 2025.

Stakeholder Impact

• **Shareholders**: Experience dilution from new stock issuances (Common Stock, Series B Preferred Stock convertible into Common Stock), but benefit from significantly improved liquidity, alleviated going concern risk, and potential long-term value creation from global expansion and commercialization efforts. Changes in warrant fair value impact reported earnings.
• **Preferred Stockholders (Series B)**: Receive cumulative dividends at 7% per annum, have conversion rights into Common Stock, and redemption rights upon certain change in control events, providing a structured return and potential equity upside.
• **Employees**: Continued investment in human capital is indicated by increased employee-related costs and equity-based compensation, including a special grant to the CEO.
• **Customers**: The expansion of PureFive resin production capacity and additional FDA LNOs suggest increased availability and versatility of sustainable polypropylene, benefiting customers seeking high-quality recycled content for various applications, including food-grade.
• **Creditors**: Improved liquidity from the capital raise reduces immediate going concern risk, enhancing the security of debt holders. The Ninth Amendment to the Credit Agreement allows for additional unsecured indebtedness, potentially impacting future credit risk profiles.

Next Steps

• Continue commissioning activities at the Ironton Facility to reach full operational capacity.
• Begin construction of the 130.0 million pound polypropylene recycling facility in Thailand in the second half of 2025, with expected operation by mid-2027.
• Advance the permitting process for the 130.0 million pound polypropylene recycling facility in Antwerp, Belgium, with required permits expected in 2026 and operation projected in 2028.
• Begin construction of the 300.0 million pound multi-line purification facility at the Augusta, Georgia location in mid-2026, with PreP facilities operational by mid-2026 and the first purification line by 2029.
• Conduct additional testing and plan further FDA LNO submissions for expanded post-consumer recycled feedstock sources and Conditions of Use.
• Evaluate different strategies and pursue additional actions to further increase liquidity position.

Key Dates

Recommendation

The successful $300 million capital raise, coupled with the alleviation of going concern doubts, provides a strong financial foundation for PureCycle Technologies. The detailed global expansion plans for new recycling facilities in Thailand, Belgium, and Augusta, Georgia, demonstrate a clear growth strategy and commitment to scaling operations significantly. The additional FDA LNO further validates the PureFive resin's market potential, particularly in high-value food-grade applications. While the company continues to report net losses as it ramps up operations, these strategic moves indicate a pivotal turning point towards commercialization and long-term profitability, making it an attractive investment for growth-oriented portfolios.

Keywords

Polypropylene Recycling, PureFive Resin, Circular Economy, Sustainability, SEC Filing, 10-Q, Capital Raise, Global Expansion, Ironton Facility, Augusta Facility, Thailand Facility, Antwerp Facility, FDA LNO, Waste Plastic, Recycled Plastic, Green Convertible Notes, Warrants, Preferred Stock